Pat Toomey: “I was a little shocked to learn that in a typical year, 2016 anyway, one out of three beneficiaries received an opioid…”

Congress can and should offer a sensible approach for the domestic regulation of these activities.

I think that there are a number of ways that you can go about creating a regulatory regime to take account of that risk.

I think there is a case to be made that there should be a regulatory regime on disclosure requirements for an issuer.

We owe it to each customer to get to the bottom of the FTX implosion, and any violations of the law should be aggressively prosecuted.